NEW YORK (GenomeWeb News) – Evotec today announced it has acquired custom cell and cell-based reagents firm Cell Culture Service for up to €2.2 million ($2.9 million).

Evotec will pay €1.15 million in cash as part of the deal. CCS is also eligible for an earn-out payment of €1.05 million due one year after the acquisition and dependent on certain revenue targets being met.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.